Global Adeno-Associated Virus Gene Therapy Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our (LP Info Research) latest study, the global Adeno-Associated Virus Gene Therapy market size was valued at US$ 1467.4 million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Adeno-Associated Virus Gene Therapy is forecast to a readjusted size of US$ 2479.2 million by 2029 with a CAGR of 7.8% during review period.
The research report highlights the growth potential of the global Adeno-Associated Virus Gene Therapy market. With recovery from influence of COVID-19 and the Russia-Ukraine War, Adeno-Associated Virus Gene Therapy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Adeno-Associated Virus Gene Therapy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Adeno-Associated Virus Gene Therapy market.
Key Features:
The report on Adeno-Associated Virus Gene Therapy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Adeno-Associated Virus Gene Therapy market. It may include historical data, market segmentation by Type (e.g., Gene Silencing, Gene Replacement), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Adeno-Associated Virus Gene Therapy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Adeno-Associated Virus Gene Therapy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Adeno-Associated Virus Gene Therapy industry. This include advancements in Adeno-Associated Virus Gene Therapy technology, Adeno-Associated Virus Gene Therapy new entrants, Adeno-Associated Virus Gene Therapy new investment, and other innovations that are shaping the future of Adeno-Associated Virus Gene Therapy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Adeno-Associated Virus Gene Therapy market. It includes factors influencing customer ' purchasing decisions, preferences for Adeno-Associated Virus Gene Therapy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Adeno-Associated Virus Gene Therapy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Adeno-Associated Virus Gene Therapy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Adeno-Associated Virus Gene Therapy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Adeno-Associated Virus Gene Therapy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Adeno-Associated Virus Gene Therapy market.
Market Segmentation:
Adeno-Associated Virus Gene Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our (LP Info Research) latest study, the global Adeno-Associated Virus Gene Therapy market size was valued at US$ 1467.4 million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Adeno-Associated Virus Gene Therapy is forecast to a readjusted size of US$ 2479.2 million by 2029 with a CAGR of 7.8% during review period.
The research report highlights the growth potential of the global Adeno-Associated Virus Gene Therapy market. With recovery from influence of COVID-19 and the Russia-Ukraine War, Adeno-Associated Virus Gene Therapy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Adeno-Associated Virus Gene Therapy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Adeno-Associated Virus Gene Therapy market.
Key Features:
The report on Adeno-Associated Virus Gene Therapy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Adeno-Associated Virus Gene Therapy market. It may include historical data, market segmentation by Type (e.g., Gene Silencing, Gene Replacement), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Adeno-Associated Virus Gene Therapy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Adeno-Associated Virus Gene Therapy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Adeno-Associated Virus Gene Therapy industry. This include advancements in Adeno-Associated Virus Gene Therapy technology, Adeno-Associated Virus Gene Therapy new entrants, Adeno-Associated Virus Gene Therapy new investment, and other innovations that are shaping the future of Adeno-Associated Virus Gene Therapy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Adeno-Associated Virus Gene Therapy market. It includes factors influencing customer ' purchasing decisions, preferences for Adeno-Associated Virus Gene Therapy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Adeno-Associated Virus Gene Therapy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Adeno-Associated Virus Gene Therapy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Adeno-Associated Virus Gene Therapy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Adeno-Associated Virus Gene Therapy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Adeno-Associated Virus Gene Therapy market.
Market Segmentation:
Adeno-Associated Virus Gene Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Gene Silencing
- Gene Replacement
- Gene Addition
- Gene Editing
- Hospitals
- Research Institute
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Creative Biolabs
- Affinia Therapeutics
- Spark Therapeutics
- AGC Biologics
- StrideBio
- SIRION Biotech
- Neurophth Biotechnology
- Belief BioMed
- BiBo Biopharma Engineering Co., Ltd.
- Beihai Kangcheng
- PackGene Biotech
- Sarepta Therapeutics
- Carbon BioSciences
- Kelonia Therapeutics
- Roche
- Remedium Bio
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Adeno-Associated Virus Gene Therapy Market Size 2018-2029
2.1.2 Adeno-Associated Virus Gene Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Adeno-Associated Virus Gene Therapy Segment by Type
2.2.1 Gene Silencing
2.2.2 Gene Replacement
2.2.3 Gene Addition
2.2.4 Gene Editing
2.3 Adeno-Associated Virus Gene Therapy Market Size by Type
2.3.1 Adeno-Associated Virus Gene Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Adeno-Associated Virus Gene Therapy Market Size Market Share by Type (2018-2023)
2.4 Adeno-Associated Virus Gene Therapy Segment by Application
2.4.1 Hospitals
2.4.2 Research Institute
2.4.3 Others
2.5 Adeno-Associated Virus Gene Therapy Market Size by Application
2.5.1 Adeno-Associated Virus Gene Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Adeno-Associated Virus Gene Therapy Market Size Market Share by Application (2018-2023)
3 ADENO-ASSOCIATED VIRUS GENE THERAPY MARKET SIZE BY PLAYER
3.1 Adeno-Associated Virus Gene Therapy Market Size Market Share by Players
3.1.1 Global Adeno-Associated Virus Gene Therapy Revenue by Players (2018-2023)
3.1.2 Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Adeno-Associated Virus Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ADENO-ASSOCIATED VIRUS GENE THERAPY BY REGIONS
4.1 Adeno-Associated Virus Gene Therapy Market Size by Regions (2018-2023)
4.2 Americas Adeno-Associated Virus Gene Therapy Market Size Growth (2018-2023)
4.3 APAC Adeno-Associated Virus Gene Therapy Market Size Growth (2018-2023)
4.4 Europe Adeno-Associated Virus Gene Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Adeno-Associated Virus Gene Therapy Market Size by Country (2018-2023)
5.2 Americas Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023)
5.3 Americas Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Adeno-Associated Virus Gene Therapy Market Size by Region (2018-2023)
6.2 APAC Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023)
6.3 APAC Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Adeno-Associated Virus Gene Therapy by Country (2018-2023)
7.2 Europe Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023)
7.3 Europe Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Adeno-Associated Virus Gene Therapy by Region (2018-2023)
8.2 Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ADENO-ASSOCIATED VIRUS GENE THERAPY MARKET FORECAST
10.1 Global Adeno-Associated Virus Gene Therapy Forecast by Regions (2024-2029)
10.1.1 Global Adeno-Associated Virus Gene Therapy Forecast by Regions (2024-2029)
10.1.2 Americas Adeno-Associated Virus Gene Therapy Forecast
10.1.3 APAC Adeno-Associated Virus Gene Therapy Forecast
10.1.4 Europe Adeno-Associated Virus Gene Therapy Forecast
10.1.5 Middle East & Africa Adeno-Associated Virus Gene Therapy Forecast
10.2 Americas Adeno-Associated Virus Gene Therapy Forecast by Country (2024-2029)
10.2.1 United States Adeno-Associated Virus Gene Therapy Market Forecast
10.2.2 Canada Adeno-Associated Virus Gene Therapy Market Forecast
10.2.3 Mexico Adeno-Associated Virus Gene Therapy Market Forecast
10.2.4 Brazil Adeno-Associated Virus Gene Therapy Market Forecast
10.3 APAC Adeno-Associated Virus Gene Therapy Forecast by Region (2024-2029)
10.3.1 China Adeno-Associated Virus Gene Therapy Market Forecast
10.3.2 Japan Adeno-Associated Virus Gene Therapy Market Forecast
10.3.3 Korea Adeno-Associated Virus Gene Therapy Market Forecast
10.3.4 Southeast Asia Adeno-Associated Virus Gene Therapy Market Forecast
10.3.5 India Adeno-Associated Virus Gene Therapy Market Forecast
10.3.6 Australia Adeno-Associated Virus Gene Therapy Market Forecast
10.4 Europe Adeno-Associated Virus Gene Therapy Forecast by Country (2024-2029)
10.4.1 Germany Adeno-Associated Virus Gene Therapy Market Forecast
10.4.2 France Adeno-Associated Virus Gene Therapy Market Forecast
10.4.3 UK Adeno-Associated Virus Gene Therapy Market Forecast
10.4.4 Italy Adeno-Associated Virus Gene Therapy Market Forecast
10.4.5 Russia Adeno-Associated Virus Gene Therapy Market Forecast
10.5 Middle East & Africa Adeno-Associated Virus Gene Therapy Forecast by Region (2024-2029)
10.5.1 Egypt Adeno-Associated Virus Gene Therapy Market Forecast
10.5.2 South Africa Adeno-Associated Virus Gene Therapy Market Forecast
10.5.3 Israel Adeno-Associated Virus Gene Therapy Market Forecast
10.5.4 Turkey Adeno-Associated Virus Gene Therapy Market Forecast
10.5.5 GCC Countries Adeno-Associated Virus Gene Therapy Market Forecast
10.6 Global Adeno-Associated Virus Gene Therapy Forecast by Type (2024-2029)
10.7 Global Adeno-Associated Virus Gene Therapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Creative Biolabs
11.1.1 Creative Biolabs Company Information
11.1.2 Creative Biolabs Adeno-Associated Virus Gene Therapy Product Offered
11.1.3 Creative Biolabs Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Creative Biolabs Main Business Overview
11.1.5 Creative Biolabs Latest Developments
11.2 Affinia Therapeutics
11.2.1 Affinia Therapeutics Company Information
11.2.2 Affinia Therapeutics Adeno-Associated Virus Gene Therapy Product Offered
11.2.3 Affinia Therapeutics Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Affinia Therapeutics Main Business Overview
11.2.5 Affinia Therapeutics Latest Developments
11.3 Spark Therapeutics
11.3.1 Spark Therapeutics Company Information
11.3.2 Spark Therapeutics Adeno-Associated Virus Gene Therapy Product Offered
11.3.3 Spark Therapeutics Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Spark Therapeutics Main Business Overview
11.3.5 Spark Therapeutics Latest Developments
11.4 AGC Biologics
11.4.1 AGC Biologics Company Information
11.4.2 AGC Biologics Adeno-Associated Virus Gene Therapy Product Offered
11.4.3 AGC Biologics Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 AGC Biologics Main Business Overview
11.4.5 AGC Biologics Latest Developments
11.5 StrideBio
11.5.1 StrideBio Company Information
11.5.2 StrideBio Adeno-Associated Virus Gene Therapy Product Offered
11.5.3 StrideBio Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 StrideBio Main Business Overview
11.5.5 StrideBio Latest Developments
11.6 SIRION Biotech
11.6.1 SIRION Biotech Company Information
11.6.2 SIRION Biotech Adeno-Associated Virus Gene Therapy Product Offered
11.6.3 SIRION Biotech Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 SIRION Biotech Main Business Overview
11.6.5 SIRION Biotech Latest Developments
11.7 Neurophth Biotechnology
11.7.1 Neurophth Biotechnology Company Information
11.7.2 Neurophth Biotechnology Adeno-Associated Virus Gene Therapy Product Offered
11.7.3 Neurophth Biotechnology Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Neurophth Biotechnology Main Business Overview
11.7.5 Neurophth Biotechnology Latest Developments
11.8 Belief BioMed
11.8.1 Belief BioMed Company Information
11.8.2 Belief BioMed Adeno-Associated Virus Gene Therapy Product Offered
11.8.3 Belief BioMed Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Belief BioMed Main Business Overview
11.8.5 Belief BioMed Latest Developments
11.9 BiBo Biopharma Engineering Co., Ltd.
11.9.1 BiBo Biopharma Engineering Co., Ltd. Company Information
11.9.2 BiBo Biopharma Engineering Co., Ltd. Adeno-Associated Virus Gene Therapy Product Offered
11.9.3 BiBo Biopharma Engineering Co., Ltd. Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 BiBo Biopharma Engineering Co., Ltd. Main Business Overview
11.9.5 BiBo Biopharma Engineering Co., Ltd. Latest Developments
11.10 Beihai Kangcheng
11.10.1 Beihai Kangcheng Company Information
11.10.2 Beihai Kangcheng Adeno-Associated Virus Gene Therapy Product Offered
11.10.3 Beihai Kangcheng Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Beihai Kangcheng Main Business Overview
11.10.5 Beihai Kangcheng Latest Developments
11.11 PackGene Biotech
11.11.1 PackGene Biotech Company Information
11.11.2 PackGene Biotech Adeno-Associated Virus Gene Therapy Product Offered
11.11.3 PackGene Biotech Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 PackGene Biotech Main Business Overview
11.11.5 PackGene Biotech Latest Developments
11.12 Sarepta Therapeutics
11.12.1 Sarepta Therapeutics Company Information
11.12.2 Sarepta Therapeutics Adeno-Associated Virus Gene Therapy Product Offered
11.12.3 Sarepta Therapeutics Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Sarepta Therapeutics Main Business Overview
11.12.5 Sarepta Therapeutics Latest Developments
11.13 Carbon BioSciences
11.13.1 Carbon BioSciences Company Information
11.13.2 Carbon BioSciences Adeno-Associated Virus Gene Therapy Product Offered
11.13.3 Carbon BioSciences Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Carbon BioSciences Main Business Overview
11.13.5 Carbon BioSciences Latest Developments
11.14 Kelonia Therapeutics
11.14.1 Kelonia Therapeutics Company Information
11.14.2 Kelonia Therapeutics Adeno-Associated Virus Gene Therapy Product Offered
11.14.3 Kelonia Therapeutics Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Kelonia Therapeutics Main Business Overview
11.14.5 Kelonia Therapeutics Latest Developments
11.15 Roche
11.15.1 Roche Company Information
11.15.2 Roche Adeno-Associated Virus Gene Therapy Product Offered
11.15.3 Roche Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Roche Main Business Overview
11.15.5 Roche Latest Developments
11.16 Remedium Bio
11.16.1 Remedium Bio Company Information
11.16.2 Remedium Bio Adeno-Associated Virus Gene Therapy Product Offered
11.16.3 Remedium Bio Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Remedium Bio Main Business Overview
11.16.5 Remedium Bio Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Adeno-Associated Virus Gene Therapy Market Size 2018-2029
2.1.2 Adeno-Associated Virus Gene Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Adeno-Associated Virus Gene Therapy Segment by Type
2.2.1 Gene Silencing
2.2.2 Gene Replacement
2.2.3 Gene Addition
2.2.4 Gene Editing
2.3 Adeno-Associated Virus Gene Therapy Market Size by Type
2.3.1 Adeno-Associated Virus Gene Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Adeno-Associated Virus Gene Therapy Market Size Market Share by Type (2018-2023)
2.4 Adeno-Associated Virus Gene Therapy Segment by Application
2.4.1 Hospitals
2.4.2 Research Institute
2.4.3 Others
2.5 Adeno-Associated Virus Gene Therapy Market Size by Application
2.5.1 Adeno-Associated Virus Gene Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Adeno-Associated Virus Gene Therapy Market Size Market Share by Application (2018-2023)
3 ADENO-ASSOCIATED VIRUS GENE THERAPY MARKET SIZE BY PLAYER
3.1 Adeno-Associated Virus Gene Therapy Market Size Market Share by Players
3.1.1 Global Adeno-Associated Virus Gene Therapy Revenue by Players (2018-2023)
3.1.2 Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Adeno-Associated Virus Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ADENO-ASSOCIATED VIRUS GENE THERAPY BY REGIONS
4.1 Adeno-Associated Virus Gene Therapy Market Size by Regions (2018-2023)
4.2 Americas Adeno-Associated Virus Gene Therapy Market Size Growth (2018-2023)
4.3 APAC Adeno-Associated Virus Gene Therapy Market Size Growth (2018-2023)
4.4 Europe Adeno-Associated Virus Gene Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Adeno-Associated Virus Gene Therapy Market Size by Country (2018-2023)
5.2 Americas Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023)
5.3 Americas Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Adeno-Associated Virus Gene Therapy Market Size by Region (2018-2023)
6.2 APAC Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023)
6.3 APAC Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Adeno-Associated Virus Gene Therapy by Country (2018-2023)
7.2 Europe Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023)
7.3 Europe Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Adeno-Associated Virus Gene Therapy by Region (2018-2023)
8.2 Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ADENO-ASSOCIATED VIRUS GENE THERAPY MARKET FORECAST
10.1 Global Adeno-Associated Virus Gene Therapy Forecast by Regions (2024-2029)
10.1.1 Global Adeno-Associated Virus Gene Therapy Forecast by Regions (2024-2029)
10.1.2 Americas Adeno-Associated Virus Gene Therapy Forecast
10.1.3 APAC Adeno-Associated Virus Gene Therapy Forecast
10.1.4 Europe Adeno-Associated Virus Gene Therapy Forecast
10.1.5 Middle East & Africa Adeno-Associated Virus Gene Therapy Forecast
10.2 Americas Adeno-Associated Virus Gene Therapy Forecast by Country (2024-2029)
10.2.1 United States Adeno-Associated Virus Gene Therapy Market Forecast
10.2.2 Canada Adeno-Associated Virus Gene Therapy Market Forecast
10.2.3 Mexico Adeno-Associated Virus Gene Therapy Market Forecast
10.2.4 Brazil Adeno-Associated Virus Gene Therapy Market Forecast
10.3 APAC Adeno-Associated Virus Gene Therapy Forecast by Region (2024-2029)
10.3.1 China Adeno-Associated Virus Gene Therapy Market Forecast
10.3.2 Japan Adeno-Associated Virus Gene Therapy Market Forecast
10.3.3 Korea Adeno-Associated Virus Gene Therapy Market Forecast
10.3.4 Southeast Asia Adeno-Associated Virus Gene Therapy Market Forecast
10.3.5 India Adeno-Associated Virus Gene Therapy Market Forecast
10.3.6 Australia Adeno-Associated Virus Gene Therapy Market Forecast
10.4 Europe Adeno-Associated Virus Gene Therapy Forecast by Country (2024-2029)
10.4.1 Germany Adeno-Associated Virus Gene Therapy Market Forecast
10.4.2 France Adeno-Associated Virus Gene Therapy Market Forecast
10.4.3 UK Adeno-Associated Virus Gene Therapy Market Forecast
10.4.4 Italy Adeno-Associated Virus Gene Therapy Market Forecast
10.4.5 Russia Adeno-Associated Virus Gene Therapy Market Forecast
10.5 Middle East & Africa Adeno-Associated Virus Gene Therapy Forecast by Region (2024-2029)
10.5.1 Egypt Adeno-Associated Virus Gene Therapy Market Forecast
10.5.2 South Africa Adeno-Associated Virus Gene Therapy Market Forecast
10.5.3 Israel Adeno-Associated Virus Gene Therapy Market Forecast
10.5.4 Turkey Adeno-Associated Virus Gene Therapy Market Forecast
10.5.5 GCC Countries Adeno-Associated Virus Gene Therapy Market Forecast
10.6 Global Adeno-Associated Virus Gene Therapy Forecast by Type (2024-2029)
10.7 Global Adeno-Associated Virus Gene Therapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Creative Biolabs
11.1.1 Creative Biolabs Company Information
11.1.2 Creative Biolabs Adeno-Associated Virus Gene Therapy Product Offered
11.1.3 Creative Biolabs Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Creative Biolabs Main Business Overview
11.1.5 Creative Biolabs Latest Developments
11.2 Affinia Therapeutics
11.2.1 Affinia Therapeutics Company Information
11.2.2 Affinia Therapeutics Adeno-Associated Virus Gene Therapy Product Offered
11.2.3 Affinia Therapeutics Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Affinia Therapeutics Main Business Overview
11.2.5 Affinia Therapeutics Latest Developments
11.3 Spark Therapeutics
11.3.1 Spark Therapeutics Company Information
11.3.2 Spark Therapeutics Adeno-Associated Virus Gene Therapy Product Offered
11.3.3 Spark Therapeutics Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Spark Therapeutics Main Business Overview
11.3.5 Spark Therapeutics Latest Developments
11.4 AGC Biologics
11.4.1 AGC Biologics Company Information
11.4.2 AGC Biologics Adeno-Associated Virus Gene Therapy Product Offered
11.4.3 AGC Biologics Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 AGC Biologics Main Business Overview
11.4.5 AGC Biologics Latest Developments
11.5 StrideBio
11.5.1 StrideBio Company Information
11.5.2 StrideBio Adeno-Associated Virus Gene Therapy Product Offered
11.5.3 StrideBio Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 StrideBio Main Business Overview
11.5.5 StrideBio Latest Developments
11.6 SIRION Biotech
11.6.1 SIRION Biotech Company Information
11.6.2 SIRION Biotech Adeno-Associated Virus Gene Therapy Product Offered
11.6.3 SIRION Biotech Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 SIRION Biotech Main Business Overview
11.6.5 SIRION Biotech Latest Developments
11.7 Neurophth Biotechnology
11.7.1 Neurophth Biotechnology Company Information
11.7.2 Neurophth Biotechnology Adeno-Associated Virus Gene Therapy Product Offered
11.7.3 Neurophth Biotechnology Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Neurophth Biotechnology Main Business Overview
11.7.5 Neurophth Biotechnology Latest Developments
11.8 Belief BioMed
11.8.1 Belief BioMed Company Information
11.8.2 Belief BioMed Adeno-Associated Virus Gene Therapy Product Offered
11.8.3 Belief BioMed Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Belief BioMed Main Business Overview
11.8.5 Belief BioMed Latest Developments
11.9 BiBo Biopharma Engineering Co., Ltd.
11.9.1 BiBo Biopharma Engineering Co., Ltd. Company Information
11.9.2 BiBo Biopharma Engineering Co., Ltd. Adeno-Associated Virus Gene Therapy Product Offered
11.9.3 BiBo Biopharma Engineering Co., Ltd. Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 BiBo Biopharma Engineering Co., Ltd. Main Business Overview
11.9.5 BiBo Biopharma Engineering Co., Ltd. Latest Developments
11.10 Beihai Kangcheng
11.10.1 Beihai Kangcheng Company Information
11.10.2 Beihai Kangcheng Adeno-Associated Virus Gene Therapy Product Offered
11.10.3 Beihai Kangcheng Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Beihai Kangcheng Main Business Overview
11.10.5 Beihai Kangcheng Latest Developments
11.11 PackGene Biotech
11.11.1 PackGene Biotech Company Information
11.11.2 PackGene Biotech Adeno-Associated Virus Gene Therapy Product Offered
11.11.3 PackGene Biotech Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 PackGene Biotech Main Business Overview
11.11.5 PackGene Biotech Latest Developments
11.12 Sarepta Therapeutics
11.12.1 Sarepta Therapeutics Company Information
11.12.2 Sarepta Therapeutics Adeno-Associated Virus Gene Therapy Product Offered
11.12.3 Sarepta Therapeutics Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Sarepta Therapeutics Main Business Overview
11.12.5 Sarepta Therapeutics Latest Developments
11.13 Carbon BioSciences
11.13.1 Carbon BioSciences Company Information
11.13.2 Carbon BioSciences Adeno-Associated Virus Gene Therapy Product Offered
11.13.3 Carbon BioSciences Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Carbon BioSciences Main Business Overview
11.13.5 Carbon BioSciences Latest Developments
11.14 Kelonia Therapeutics
11.14.1 Kelonia Therapeutics Company Information
11.14.2 Kelonia Therapeutics Adeno-Associated Virus Gene Therapy Product Offered
11.14.3 Kelonia Therapeutics Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Kelonia Therapeutics Main Business Overview
11.14.5 Kelonia Therapeutics Latest Developments
11.15 Roche
11.15.1 Roche Company Information
11.15.2 Roche Adeno-Associated Virus Gene Therapy Product Offered
11.15.3 Roche Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Roche Main Business Overview
11.15.5 Roche Latest Developments
11.16 Remedium Bio
11.16.1 Remedium Bio Company Information
11.16.2 Remedium Bio Adeno-Associated Virus Gene Therapy Product Offered
11.16.3 Remedium Bio Adeno-Associated Virus Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Remedium Bio Main Business Overview
11.16.5 Remedium Bio Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Adeno-Associated Virus Gene Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Gene Silencing
Table 3. Major Players of Gene Replacement
Table 4. Major Players of Gene Addition
Table 5. Major Players of Gene Editing
Table 6. Adeno-Associated Virus Gene Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Adeno-Associated Virus Gene Therapy Market Size Market Share by Type (2018-2023)
Table 9. Adeno-Associated Virus Gene Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Adeno-Associated Virus Gene Therapy Market Size Market Share by Application (2018-2023)
Table 12. Global Adeno-Associated Virus Gene Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Player (2018-2023)
Table 14. Adeno-Associated Virus Gene Therapy Key Players Head office and Products Offered
Table 15. Adeno-Associated Virus Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Adeno-Associated Virus Gene Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Adeno-Associated Virus Gene Therapy Market Size Market Share by Regions (2018-2023)
Table 20. Global Adeno-Associated Virus Gene Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Adeno-Associated Virus Gene Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Adeno-Associated Virus Gene Therapy Market Size Market Share by Country (2018-2023)
Table 24. Americas Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Adeno-Associated Virus Gene Therapy Market Size Market Share by Type (2018-2023)
Table 26. Americas Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Adeno-Associated Virus Gene Therapy Market Size Market Share by Application (2018-2023)
Table 28. APAC Adeno-Associated Virus Gene Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Adeno-Associated Virus Gene Therapy Market Size Market Share by Region (2018-2023)
Table 30. APAC Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Adeno-Associated Virus Gene Therapy Market Size Market Share by Type (2018-2023)
Table 32. APAC Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Adeno-Associated Virus Gene Therapy Market Size Market Share by Application (2018-2023)
Table 34. Europe Adeno-Associated Virus Gene Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Adeno-Associated Virus Gene Therapy Market Size Market Share by Country (2018-2023)
Table 36. Europe Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Adeno-Associated Virus Gene Therapy Market Size Market Share by Type (2018-2023)
Table 38. Europe Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Adeno-Associated Virus Gene Therapy Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Adeno-Associated Virus Gene Therapy
Table 47. Key Market Challenges & Risks of Adeno-Associated Virus Gene Therapy
Table 48. Key Industry Trends of Adeno-Associated Virus Gene Therapy
Table 49. Global Adeno-Associated Virus Gene Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Adeno-Associated Virus Gene Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Adeno-Associated Virus Gene Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Adeno-Associated Virus Gene Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Creative Biolabs Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 54. Creative Biolabs Adeno-Associated Virus Gene Therapy Product Offered
Table 55. Creative Biolabs Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Creative Biolabs Main Business
Table 57. Creative Biolabs Latest Developments
Table 58. Affinia Therapeutics Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 59. Affinia Therapeutics Adeno-Associated Virus Gene Therapy Product Offered
Table 60. Affinia Therapeutics Main Business
Table 61. Affinia Therapeutics Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Affinia Therapeutics Latest Developments
Table 63. Spark Therapeutics Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 64. Spark Therapeutics Adeno-Associated Virus Gene Therapy Product Offered
Table 65. Spark Therapeutics Main Business
Table 66. Spark Therapeutics Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Spark Therapeutics Latest Developments
Table 68. AGC Biologics Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 69. AGC Biologics Adeno-Associated Virus Gene Therapy Product Offered
Table 70. AGC Biologics Main Business
Table 71. AGC Biologics Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. AGC Biologics Latest Developments
Table 73. StrideBio Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 74. StrideBio Adeno-Associated Virus Gene Therapy Product Offered
Table 75. StrideBio Main Business
Table 76. StrideBio Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. StrideBio Latest Developments
Table 78. SIRION Biotech Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 79. SIRION Biotech Adeno-Associated Virus Gene Therapy Product Offered
Table 80. SIRION Biotech Main Business
Table 81. SIRION Biotech Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. SIRION Biotech Latest Developments
Table 83. Neurophth Biotechnology Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 84. Neurophth Biotechnology Adeno-Associated Virus Gene Therapy Product Offered
Table 85. Neurophth Biotechnology Main Business
Table 86. Neurophth Biotechnology Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Neurophth Biotechnology Latest Developments
Table 88. Belief BioMed Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 89. Belief BioMed Adeno-Associated Virus Gene Therapy Product Offered
Table 90. Belief BioMed Main Business
Table 91. Belief BioMed Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Belief BioMed Latest Developments
Table 93. BiBo Biopharma Engineering Co., Ltd. Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 94. BiBo Biopharma Engineering Co., Ltd. Adeno-Associated Virus Gene Therapy Product Offered
Table 95. BiBo Biopharma Engineering Co., Ltd. Main Business
Table 96. BiBo Biopharma Engineering Co., Ltd. Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. BiBo Biopharma Engineering Co., Ltd. Latest Developments
Table 98. Beihai Kangcheng Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 99. Beihai Kangcheng Adeno-Associated Virus Gene Therapy Product Offered
Table 100. Beihai Kangcheng Main Business
Table 101. Beihai Kangcheng Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Beihai Kangcheng Latest Developments
Table 103. PackGene Biotech Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 104. PackGene Biotech Adeno-Associated Virus Gene Therapy Product Offered
Table 105. PackGene Biotech Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. PackGene Biotech Main Business
Table 107. PackGene Biotech Latest Developments
Table 108. Sarepta Therapeutics Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 109. Sarepta Therapeutics Adeno-Associated Virus Gene Therapy Product Offered
Table 110. Sarepta Therapeutics Main Business
Table 111. Sarepta Therapeutics Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. Sarepta Therapeutics Latest Developments
Table 113. Carbon BioSciences Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 114. Carbon BioSciences Adeno-Associated Virus Gene Therapy Product Offered
Table 115. Carbon BioSciences Main Business
Table 116. Carbon BioSciences Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Carbon BioSciences Latest Developments
Table 118. Kelonia Therapeutics Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 119. Kelonia Therapeutics Adeno-Associated Virus Gene Therapy Product Offered
Table 120. Kelonia Therapeutics Main Business
Table 121. Kelonia Therapeutics Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. Kelonia Therapeutics Latest Developments
Table 123. Roche Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 124. Roche Adeno-Associated Virus Gene Therapy Product Offered
Table 125. Roche Main Business
Table 126. Roche Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Roche Latest Developments
Table 128. Remedium Bio Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 129. Remedium Bio Adeno-Associated Virus Gene Therapy Product Offered
Table 130. Remedium Bio Main Business
Table 131. Remedium Bio Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 132. Remedium Bio Latest Developments
Table 1. Adeno-Associated Virus Gene Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Gene Silencing
Table 3. Major Players of Gene Replacement
Table 4. Major Players of Gene Addition
Table 5. Major Players of Gene Editing
Table 6. Adeno-Associated Virus Gene Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Adeno-Associated Virus Gene Therapy Market Size Market Share by Type (2018-2023)
Table 9. Adeno-Associated Virus Gene Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Adeno-Associated Virus Gene Therapy Market Size Market Share by Application (2018-2023)
Table 12. Global Adeno-Associated Virus Gene Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Player (2018-2023)
Table 14. Adeno-Associated Virus Gene Therapy Key Players Head office and Products Offered
Table 15. Adeno-Associated Virus Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Adeno-Associated Virus Gene Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Adeno-Associated Virus Gene Therapy Market Size Market Share by Regions (2018-2023)
Table 20. Global Adeno-Associated Virus Gene Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Adeno-Associated Virus Gene Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Adeno-Associated Virus Gene Therapy Market Size Market Share by Country (2018-2023)
Table 24. Americas Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Adeno-Associated Virus Gene Therapy Market Size Market Share by Type (2018-2023)
Table 26. Americas Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Adeno-Associated Virus Gene Therapy Market Size Market Share by Application (2018-2023)
Table 28. APAC Adeno-Associated Virus Gene Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Adeno-Associated Virus Gene Therapy Market Size Market Share by Region (2018-2023)
Table 30. APAC Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Adeno-Associated Virus Gene Therapy Market Size Market Share by Type (2018-2023)
Table 32. APAC Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Adeno-Associated Virus Gene Therapy Market Size Market Share by Application (2018-2023)
Table 34. Europe Adeno-Associated Virus Gene Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Adeno-Associated Virus Gene Therapy Market Size Market Share by Country (2018-2023)
Table 36. Europe Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Adeno-Associated Virus Gene Therapy Market Size Market Share by Type (2018-2023)
Table 38. Europe Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Adeno-Associated Virus Gene Therapy Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Adeno-Associated Virus Gene Therapy
Table 47. Key Market Challenges & Risks of Adeno-Associated Virus Gene Therapy
Table 48. Key Industry Trends of Adeno-Associated Virus Gene Therapy
Table 49. Global Adeno-Associated Virus Gene Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Adeno-Associated Virus Gene Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Adeno-Associated Virus Gene Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Adeno-Associated Virus Gene Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Creative Biolabs Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 54. Creative Biolabs Adeno-Associated Virus Gene Therapy Product Offered
Table 55. Creative Biolabs Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Creative Biolabs Main Business
Table 57. Creative Biolabs Latest Developments
Table 58. Affinia Therapeutics Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 59. Affinia Therapeutics Adeno-Associated Virus Gene Therapy Product Offered
Table 60. Affinia Therapeutics Main Business
Table 61. Affinia Therapeutics Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Affinia Therapeutics Latest Developments
Table 63. Spark Therapeutics Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 64. Spark Therapeutics Adeno-Associated Virus Gene Therapy Product Offered
Table 65. Spark Therapeutics Main Business
Table 66. Spark Therapeutics Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Spark Therapeutics Latest Developments
Table 68. AGC Biologics Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 69. AGC Biologics Adeno-Associated Virus Gene Therapy Product Offered
Table 70. AGC Biologics Main Business
Table 71. AGC Biologics Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. AGC Biologics Latest Developments
Table 73. StrideBio Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 74. StrideBio Adeno-Associated Virus Gene Therapy Product Offered
Table 75. StrideBio Main Business
Table 76. StrideBio Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. StrideBio Latest Developments
Table 78. SIRION Biotech Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 79. SIRION Biotech Adeno-Associated Virus Gene Therapy Product Offered
Table 80. SIRION Biotech Main Business
Table 81. SIRION Biotech Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. SIRION Biotech Latest Developments
Table 83. Neurophth Biotechnology Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 84. Neurophth Biotechnology Adeno-Associated Virus Gene Therapy Product Offered
Table 85. Neurophth Biotechnology Main Business
Table 86. Neurophth Biotechnology Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Neurophth Biotechnology Latest Developments
Table 88. Belief BioMed Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 89. Belief BioMed Adeno-Associated Virus Gene Therapy Product Offered
Table 90. Belief BioMed Main Business
Table 91. Belief BioMed Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Belief BioMed Latest Developments
Table 93. BiBo Biopharma Engineering Co., Ltd. Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 94. BiBo Biopharma Engineering Co., Ltd. Adeno-Associated Virus Gene Therapy Product Offered
Table 95. BiBo Biopharma Engineering Co., Ltd. Main Business
Table 96. BiBo Biopharma Engineering Co., Ltd. Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. BiBo Biopharma Engineering Co., Ltd. Latest Developments
Table 98. Beihai Kangcheng Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 99. Beihai Kangcheng Adeno-Associated Virus Gene Therapy Product Offered
Table 100. Beihai Kangcheng Main Business
Table 101. Beihai Kangcheng Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Beihai Kangcheng Latest Developments
Table 103. PackGene Biotech Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 104. PackGene Biotech Adeno-Associated Virus Gene Therapy Product Offered
Table 105. PackGene Biotech Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. PackGene Biotech Main Business
Table 107. PackGene Biotech Latest Developments
Table 108. Sarepta Therapeutics Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 109. Sarepta Therapeutics Adeno-Associated Virus Gene Therapy Product Offered
Table 110. Sarepta Therapeutics Main Business
Table 111. Sarepta Therapeutics Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. Sarepta Therapeutics Latest Developments
Table 113. Carbon BioSciences Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 114. Carbon BioSciences Adeno-Associated Virus Gene Therapy Product Offered
Table 115. Carbon BioSciences Main Business
Table 116. Carbon BioSciences Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Carbon BioSciences Latest Developments
Table 118. Kelonia Therapeutics Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 119. Kelonia Therapeutics Adeno-Associated Virus Gene Therapy Product Offered
Table 120. Kelonia Therapeutics Main Business
Table 121. Kelonia Therapeutics Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. Kelonia Therapeutics Latest Developments
Table 123. Roche Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 124. Roche Adeno-Associated Virus Gene Therapy Product Offered
Table 125. Roche Main Business
Table 126. Roche Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Roche Latest Developments
Table 128. Remedium Bio Details, Company Type, Adeno-Associated Virus Gene Therapy Area Served and Its Competitors
Table 129. Remedium Bio Adeno-Associated Virus Gene Therapy Product Offered
Table 130. Remedium Bio Main Business
Table 131. Remedium Bio Adeno-Associated Virus Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 132. Remedium Bio Latest Developments
LIST OF FIGURES
Figure 1. Adeno-Associated Virus Gene Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Adeno-Associated Virus Gene Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Adeno-Associated Virus Gene Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Adeno-Associated Virus Gene Therapy Sales Market Share by Country/Region (2022)
Figure 8. Adeno-Associated Virus Gene Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Adeno-Associated Virus Gene Therapy Market Size Market Share by Type in 2022
Figure 10. Adeno-Associated Virus Gene Therapy in Hospitals
Figure 11. Global Adeno-Associated Virus Gene Therapy Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. Adeno-Associated Virus Gene Therapy in Research Institute
Figure 13. Global Adeno-Associated Virus Gene Therapy Market: Research Institute (2018-2023) & ($ Millions)
Figure 14. Adeno-Associated Virus Gene Therapy in Others
Figure 15. Global Adeno-Associated Virus Gene Therapy Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Adeno-Associated Virus Gene Therapy Market Size Market Share by Application in 2022
Figure 17. Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Player in 2022
Figure 18. Global Adeno-Associated Virus Gene Therapy Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Adeno-Associated Virus Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 20. APAC Adeno-Associated Virus Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 21. Europe Adeno-Associated Virus Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 23. Americas Adeno-Associated Virus Gene Therapy Value Market Share by Country in 2022
Figure 24. United States Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Adeno-Associated Virus Gene Therapy Market Size Market Share by Region in 2022
Figure 29. APAC Adeno-Associated Virus Gene Therapy Market Size Market Share by Type in 2022
Figure 30. APAC Adeno-Associated Virus Gene Therapy Market Size Market Share by Application in 2022
Figure 31. China Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Adeno-Associated Virus Gene Therapy Market Size Market Share by Country in 2022
Figure 38. Europe Adeno-Associated Virus Gene Therapy Market Size Market Share by Type (2018-2023)
Figure 39. Europe Adeno-Associated Virus Gene Therapy Market Size Market Share by Application (2018-2023)
Figure 40. Germany Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 54. APAC Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 55. Europe Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 57. United States Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 58. Canada Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 61. China Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Japan Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 63. Korea Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 65. India Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 66. Australia Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 67. Germany Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 68. France Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 69. UK Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 70. Italy Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 71. Russia Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 72. Spain Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 75. Israel Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 78. Global Adeno-Associated Virus Gene Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Adeno-Associated Virus Gene Therapy Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Adeno-Associated Virus Gene Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Adeno-Associated Virus Gene Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Adeno-Associated Virus Gene Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Adeno-Associated Virus Gene Therapy Sales Market Share by Country/Region (2022)
Figure 8. Adeno-Associated Virus Gene Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Adeno-Associated Virus Gene Therapy Market Size Market Share by Type in 2022
Figure 10. Adeno-Associated Virus Gene Therapy in Hospitals
Figure 11. Global Adeno-Associated Virus Gene Therapy Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. Adeno-Associated Virus Gene Therapy in Research Institute
Figure 13. Global Adeno-Associated Virus Gene Therapy Market: Research Institute (2018-2023) & ($ Millions)
Figure 14. Adeno-Associated Virus Gene Therapy in Others
Figure 15. Global Adeno-Associated Virus Gene Therapy Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Adeno-Associated Virus Gene Therapy Market Size Market Share by Application in 2022
Figure 17. Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Player in 2022
Figure 18. Global Adeno-Associated Virus Gene Therapy Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Adeno-Associated Virus Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 20. APAC Adeno-Associated Virus Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 21. Europe Adeno-Associated Virus Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 23. Americas Adeno-Associated Virus Gene Therapy Value Market Share by Country in 2022
Figure 24. United States Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Adeno-Associated Virus Gene Therapy Market Size Market Share by Region in 2022
Figure 29. APAC Adeno-Associated Virus Gene Therapy Market Size Market Share by Type in 2022
Figure 30. APAC Adeno-Associated Virus Gene Therapy Market Size Market Share by Application in 2022
Figure 31. China Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Adeno-Associated Virus Gene Therapy Market Size Market Share by Country in 2022
Figure 38. Europe Adeno-Associated Virus Gene Therapy Market Size Market Share by Type (2018-2023)
Figure 39. Europe Adeno-Associated Virus Gene Therapy Market Size Market Share by Application (2018-2023)
Figure 40. Germany Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Adeno-Associated Virus Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 54. APAC Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 55. Europe Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 57. United States Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 58. Canada Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 61. China Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Japan Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 63. Korea Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 65. India Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 66. Australia Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 67. Germany Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 68. France Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 69. UK Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 70. Italy Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 71. Russia Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 72. Spain Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 75. Israel Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Adeno-Associated Virus Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 78. Global Adeno-Associated Virus Gene Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Adeno-Associated Virus Gene Therapy Market Size Market Share Forecast by Application (2024-2029)
